United Therapeutics CFO sells shares amid stock volatility.

United Therapeutics Corporation [UTHR] announces that Chief Financial Officer and Treasurer Edgmond James has sold a total of 288 shares at $532.59/share, 200 shares at $522.36/share, 577 shares at $530.64/share, 2620 shares at $529.04/share, 587 shares at $531.49/share, 642 shares at $533.6/share, 440 shares at $535.34/share, 506 shares at $534.6/share, 640 shares at $519.3/share, 80 shares at $527.49/share, 200 shares at $518.28/share, 520 shares at $526.57/share, 440 shares at $524.2/share, 875 shares at $520.62/share, and 10000 shares at $135.42/share on March 23, 2026. Director Judy D. Olian sold 200 shares at $530/share, while Director and Chairperson & CEO Martine A. Rothblatt sold 240 shares at $518.39/share. Additionally, James sold 906 shares at $519.29/share, 867 shares at $520.54/share, 1320 shares at $521.38/share, 160 shares at $522.19/share, 647 shares at $524.15/share, 400 shares at $525.43/share, 640 shares at $526.59/share, and 9500 shares at $146.03/share on the same day. James also sold 342 shares at $529.8/share, 703 shares at $530.91/share, 671 shares at $531.65/share, 364 shares at $533.15/share, 920 shares at $533.93/share, 830 shares at $535.12/share, and 370 shares at $536.16/share. Finally, James sold 120 shares at $527.57/share on March 23, 2026.